In the present study, we show that the development of the EBV-associated and life-threatening malignant diseases EBV+HL and EBV+nHL is associated with distinct virus- and host-associated factors which affect NKG2C+ and NKG2A+ NK cell responses. This evidence concerns the gene KLRC2 and non-Hodgkin lymphoma.